Tenvie Therapeutics has dosed the first participant in its Phase I clinical trial of TNV108 for peripheral neuropathies treatment.
The post Tenvie doses first subject in Phase I TNV108 trial for peripheral neuropathies appeared first on Clinical Trials Arena.
The sector recorded 12 bankruptcy filings in the first quarter, up 33% from the fourth quarter of 2025, according to the analysis by Gibbins Advisors.
House Oversight and Government Reform Committee Democrats are raising questions about a number of unusual aspects agreed to by the panel’s Republicans for a slated deposition …
Nashville, Tenn.-based HCA Healthcare has laid off a “small portion” of its workforce in non-direct patient care roles, a system spokesperson said in a May 4 …
The cruise ship at the center of a deadly outbreak of hantavirus has been refused permission to dock, with 149 people still on board — two …